← Eichor
Condition: Lymphatic Malformation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Lymphatic Malformation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Phase N/A · 6 location(s) · Genetix Biotherapeutics Inc. · NCT06271512Cord Blood S100B Protein Levels in Neonates Following Intrauterine Transfusions for HDFN-Associated Fetal Anemia
Phase N/A · 1 location(s) · Institute of Mother and Child, Warsaw, Poland · NCT06984445The Severe Von Willebrand Disease (sVWD) Patient Registry
Phase N/A · 1 location(s) · VWD Connect Foundation · NCT05437536A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Pr
Phase 4 · 2 location(s) · Sanofi · NCT06145373Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001456Effect of EMDR for Reduction of Pain Interference in Children With Sickle Cell Disease
NA · 1 location(s) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC · NCT07001631A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
NA · 1 location(s) · University of Florida · NCT04484272Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute M
Phase 1 · 22 location(s) · National Cancer Institute (NCI) · NCT06484062Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07358013A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
Phase 2 · 1 location(s) · Hemab ApS · NCT07347249Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
NA · 1 location(s) · Children's National Research Institute · NCT05099874Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A P
Phase N/A · 59 location(s) · Octapharma · NCT03695978Stroke Prevention in Nigeria 2 Trial
Phase 4 · 2 location(s) · Vanderbilt University Medical Center · NCT06526117Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265)
Phase 1/Phase 2 · 44 location(s) · Regeneron Pharmaceuticals · NCT06379789Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Phase N/A · 1 location(s) · Imperial College London · NCT00230620The HOPE Biobank Resource (BMT CTN 2402 HOPE)
Phase N/A · 6 location(s) · Medical College of Wisconsin · NCT07227155A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Phase 3 · 2 location(s) · Hoffmann-La Roche · NCT07416526Gene Therapy for Chinese Hemophilia A
NA · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04728841Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05546593Effect of Incentive Respiratory Training on Pulmonary Functions and Functional Capacity in Children With B-thalassemia M
NA · 1 location(s) · Rawan Mohammed Khairy Mostafa Elsawy · NCT07112703Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
Phase N/A · 1 location(s) · Karolinska Institutet · NCT02453542Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Phase 1/Phase 2 · 25 location(s) · Vega Therapeutics, Inc · NCT05776069Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Ultrasound Acute Chest Syndrome Sickle Cell Disease
NA · 1 location(s) · Indiana University · NCT06880679World Bleeding Disorders Registry
Phase N/A · 1 location(s) · World Federation of Hemophilia · NCT03327779AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966Geranylgeraniol Supplementation in Patients With Mevalonate Kinase Deficiency
NA · 1 location(s) · University Hospital, Motol · NCT06497829Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
Phase 2 · 1 location(s) · West China Hospital · NCT06437158Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
Phase 2 · 1 location(s) · University of California, Davis · NCT06016634
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.